xRead - Olfactory Disorders (September 2023)

20426984, 2022, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.22929, Wiley Online Library on [04/09/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

652

INTERNATIONAL CONSENSUS ON OLFACTION

1038. Bakker K, Catroppa C, Anderson V. Olfactory dysfunction in pediatric traumatic brain injury: a systematic review. JNeuro trauma . 2014;31:308–314. 1039. Schriever VA, Gupta N, Pade J, Szewczynska M, Hummel T. Olfactory function following nasal surgery: a 1-year follow-up. Eur Arch Otorhinolaryngol . 2013;270:107–111. 1040. Brion M, de Timary P, Vander Stappen C, et al. Chemosensory dysfunction in alcohol-related disorders: A joint exploration of olfaction and taste. Chem Senses . 2015;40:605–608. 1041. Silva MM, Mercer PB, Witt MC, Pessoa RR. Olfactory dys function in Alzheimer’s disease Systematic review and meta analysis. Dement Neuropsychol . 2018;12:123–132. 1042. Carnemolla SE, Hsieh JW, Sipione R, et al. Olfactory dys function in frontotemporal dementia and psychiatric disor ders: A systematic review. Neurosci Biobehav Rev . 2020;118: 588–611. 1043. Choi JS, Hur K, Chow M, Shen J, Wrobel B. Olfactory dysfunc tion and cognition among older adults in the United States. Int Forum Allergy Rhinol . 2018;8:648–654. 1044. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory func tioning in Alzheimer’s and Parkinson’s diseases. Arch Neurol . 1998;55:84–90. 1045. Fullard ME, Morley JF, Duda JE. Olfactory dysfunction as an early biomarker in Parkinson’s disease. Neurosci Bull . 2017;33:515–525. 1046. Zou YM, Lu D, Liu LP, Zhang HH, Zhou YY. Olfactory dys function in Alzheimer’s disease. Neuropsychiatr Dis Treat . 2016;12:869–875. 1047. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters E, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. AnnNeurol . 2004;56:173–181. 1048. Kohli P, Schlosser RJ, Storck K, Soler ZM. Olfactory cleft com puted tomography analysis and olfaction in chronic rhinosi nusitis. Am J Rhinol Allergy . 2016;30:402–406. 1049. Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg . 1997;117(3 pt 2): S35–40. 1050. Soler ZM, Hyer JM, Karnezis TT, Schlosser RJ. The Olfac tory Cleft Endoscopy Scale correlates with olfactory metrics in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol . 2016;6:293–298. 1051. Armstrong JE, Laing DG, Wilkes FJ, Laing ON. Olfactory func tion in Australian aboriginal children and chronic otitis media. Chem Senses . 2008;33:503–507. 1052. Coelho DH, Costanzo RM. Posttraumatic olfactory dysfunc tion. Auris Nasus Larynx . 2016;43:137–143. 1053. Yildirim D, Altundag A, Tekcan Sanli DE, et al. A new perspec tive on imaging of olfactory dysfunction: Does size matter? Eur JRadiol . 2020;132: 109290. 1054. Kandemirli SG, Altundag A, Yildirim D, Tekcan Sanli DE, Saatci O. Olfactory bulb MRI and paranasal sinus CT find ings in persistent COVID-19 anosmia. Acad Radiol . 2021;28: 28–35. 1055. Biacabe B, Faulcon P, Amanou L, Bonfils P. Olfactory cleft disease: an analysis of 13 cases. Otolaryngol Head Neck Surg . 2004;130:202–208. 1056. Mueller C, Temmel AF, Toth J, Quint C, Herneth A, Hummel T. Computed tomography scans in the evaluation of patients with olfactory dysfunction. AmJRhinol . 2006;20:109–112.

1019. Hayes JE, Jinks AL. Evaluation of smoking on olfactory thresh olds of phenyl ethyl alcohol and n-butanol. Physiol Behav . 2012;107:177–180. 1020. Rosenblatt MR, Olmstead RE, Iwamoto-Schaap PN, Jarvik ME. Olfactory thresholds for nicotine and menthol in smokers (abstinent and nonabstinent) and nonsmokers. Physiol Behav . 1998;65:575–579. 1021. Ahlström R, Berglund B, Berglund U, Engen T, Lindvall T. A comparison of odor perception in smokers, nonsmokers, and passive smokers. Am J Otolaryngol . 1987;8:1–6. 1022. Cometto-Muñiz JE, Cain WS. Perception of nasal pungency in smokers and nonsmokers. Physiol Behav . 1982;29:727–731. 1023. Hald MO, Fjaeldstad A, Kjær S, Ovesen T. Characterisation of patients with idiopathic olfactory dysfunction and plan for clinical follow-up. DanMedJ . 2020;67: A06200421. 1024. Hoekman PK, Houlton JJ, Seiden AM. The utility of magnetic resonance imaging in the diagnostic evaluation of idiopathic olfactory loss. Laryngoscope . 2014;124:365–368. 1025. Haehner A, Masala C, Walter S, Reichmann H, Hummel T. Incidence of Parkinson’s disease in a large patient cohort with idiopathic smell and taste loss. JNeurol . 2018;266:339–345. 1026. Seubert J, Freiherr J, Frasnelli J, Hummel T, Lundström J. Orbitofrontal cortex and olfactory bulb volume predict distinct aspects of olfactory performance in healthy subjects. Cereb Cortex . 2013;23:2448–2456. 1027. Frasnelli J, Lundström JN, Boyle JA, Djordjevic J, Zatorre RJ, Jones-Gotman M. Neuroanatomical correlates of olfactory performance. Exp Brain Res . 2010;201:1–11. 1028. Bitter T, Gudziol H, Burmeister HP, Mentzel HJ, Guntinas Lichius O, Gaser C. Anosmia leads to a loss of gray matter in cortical brain areas. Chem Senses . 2010;35:407–415. 1029. Yao L, Pinto JM, Yi X, Li L, Peng P, Wei Y. Gray matter vol ume reduction of olfactory cortices in patients with idiopathic olfactory loss. Chem Senses . 2014;39:755–760. 1030. Hummel T, Urbig A, Huart C, Duprez T, Rombaux P. Volume of olfactory bulb and depth of olfactory sulcus in 378 consecu tive patients with olfactory loss. JNeurol . 2015;262:1046–1051. 1031. Rombaux P, Mouraux A, Bertrand B, Nicolas G, Duprez T, Hummel T. Olfactory function and olfactory bulb volume in patients with postinfectious olfactory loss. Laryngoscope . 2006;116:436–439. 1032. Liu J, Pinto JM, Yang L, Yao L, Miao X, Wei Y. Evaluation of idiopathic olfactory loss with chemosensory event-related potentials and magnetic resonance imaging. Int Forum Allergy Rhinol . 2018;8:1315–1322. 1033. Landis BN, Konnerth CG, Hummel T. A study on the fre quency of olfactory dysfunction. Laryngoscope . 2004;114:1764– 1769. 1034. Miwa T, Ikeda K, Ishibashi T, et al. Clinical practice guidelines for the management of olfacto–y dysfunction - secondary pub lication. Auris Nasus Larynx . 2019;46:653–662. 1035. Stuck BA, Beule A, Damm M, et al. [Position paper “Chemosensory testing for expert opinion in smell disorders”]. Laryngorhinootologie . 2014;93:327–329. 1036. Whitcroft KL, Hummel T. Clinical diagnosis and current man agement strategies for olfactory dysfunction: A review. JAMA Otolaryngol Head Neck Surg . 2019;145:846–853. 1037. Schofield PW, Moore TM, Gardner A. Traumatic brain injury and olfaction: a systematic review. Front Neurol . 2014;5:5.